94 related articles for article (PubMed ID: 4048970)
1. Adjuvant therapy in rectal cancer: a protocol proposal.
Mayer RJ
Semin Oncol; 1985 Sep; 12(3 Suppl 4):116-20. PubMed ID: 4048970
[TBL] [Abstract][Full Text] [Related]
2. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
[TBL] [Abstract][Full Text] [Related]
3. Prolongation of the disease-free interval in surgically treated rectal carcinoma.
Gastrointestinal Tumor Study Group
N Engl J Med; 1985 Jun; 312(23):1465-72. PubMed ID: 2859523
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.
Fisher B; Wolmark N; Rockette H; Redmond C; Deutsch M; Wickerham DL; Fisher ER; Caplan R; Jones J; Lerner H
J Natl Cancer Inst; 1988 Mar; 80(1):21-9. PubMed ID: 3276900
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.
J Clin Oncol; 1992 Apr; 10(4):549-57. PubMed ID: 1548520
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
7. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.
O'Connell MJ; Martenson JA; Wieand HS; Krook JE; Macdonald JS; Haller DG; Mayer RJ; Gunderson LL; Rich TA
N Engl J Med; 1994 Aug; 331(8):502-7. PubMed ID: 8041415
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant postoperative therapy of gastrointestinal malignancies.
Ilson DH; Kelsen DP
Oncology (Williston Park); 1994 Jul; 8(7):75-83; discussion 83, 88-90, 95. PubMed ID: 7917843
[TBL] [Abstract][Full Text] [Related]
9. NCI advocates use of adjuvant therapy for rectal cancer.
Am Fam Physician; 1991 Apr; 43(4):1440-2, 1444. PubMed ID: 2008825
[No Abstract] [Full Text] [Related]
10. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer.
Sugarbaker PH; Gianola FJ; Speyer JL; Wesley R; Barofsky I; Myers CE
Semin Oncol; 1985 Sep; 12(3 Suppl 4):101-11. PubMed ID: 3901269
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials referral resource. Adjuvant therapy for rectal cancer.
Cheson BD
Oncology (Williston Park); 1991 May; 5(5):61-2, 64. PubMed ID: 1832006
[No Abstract] [Full Text] [Related]
13. Colorectal cancer: speculations on the role of intraperitoneal therapy.
Muggia FM
Semin Oncol; 1985 Sep; 12(3 Suppl 4):112-5. PubMed ID: 4048969
[TBL] [Abstract][Full Text] [Related]
14. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.
Johnston PG; Fisher ER; Rockette HE; Fisher B; Wolmark N; Drake JC; Chabner BA; Allegra CJ
J Clin Oncol; 1994 Dec; 12(12):2640-7. PubMed ID: 7989939
[TBL] [Abstract][Full Text] [Related]
15. Combined modality adjuvant treatment of high-risk rectal cancer: a treatment of choice or a choice of treatment?
Wils J; Wagener DJ
Ann Oncol; 1992 Mar; 3(3):197-9. PubMed ID: 1586617
[No Abstract] [Full Text] [Related]
16. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for rectal cancer: is 5-FU effective without MeCCNU.
Willen M
Oncology (Williston Park); 1989 Dec; 3(12):11. PubMed ID: 2641312
[No Abstract] [Full Text] [Related]
18. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
19. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
Kodaira S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
